Wallace Akerley
0000-0002-3090-4778
Publication & Citation Trends
Publications
0 total
Loss of the endocytic tumor suppressor HD-PTP phenocopies LKB1 and promotes RAS-driven oncogenesis OA
Cited by 1
Semantic Scholar
1723P CLEC3B mRNA expression levels are linked to distinct genetic backgrounds, transcriptomic signatures and survival in NSCLC
Cited by 0
Semantic Scholar
P24.01 Turnaround Time and Variant Prevalence of a Blood-based KRAS Test in Patients With NSCLC OA
Cited by 0
Semantic Scholar
994-P: Prevalence and Persistence of Post-diagnosis Hyperglycemia in Cancer Patients
Cited by 0
Semantic Scholar
1010-P: Prevalence of Acute Diabetes Complications following Cancer Diagnosis and Treatment
Cited by 0
Semantic Scholar
1030TiP An open-label multicenter phase Ib study of AN0025, a selective inhibitor of the prostaglandin E2 receptor-type-4 receptor, in combination with pembrolizumab in patients with advanced solid tumors OA
Cited by 0
Semantic Scholar
PL02.08 Registrational Results of LIBRETTO-001: A Phase 1/2 Trial of LOXO-292 in Patients with RET Fusion-Positive Lung Cancers OA
Cited by 79
Semantic Scholar
JAMA Peer Reviewers in 2011
Cited by 0
Semantic Scholar
Research Topics
Lung Cancer Treatments and Mutations
(152)
Lung Cancer Research Studies
(69)
Lung Cancer Diagnosis and Treatment
(59)
Cancer Genomics and Diagnostics
(33)
Colorectal Cancer Treatments and Studies
(31)
Affiliations
Boston University
University of Southern California
University of Maryland, Baltimore
Boston Medical Center
Dartmouth–Hitchcock Medical Center